Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134075) titled 'Subsequent Primary Cancers After Esophageal Squamous Cell Carcinoma: Risk Patterns, Multistate Transitions, and Dynamic Risk Stratification in SEER and a Clinical Cohort from a High-Incidence Region in China' on Oct. 10.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Cancer Hospital of Shantou University Medical College
Condition:
Second primary cancer in patients with esophageal squamous cell carcinoma
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-05
Target Sample Size: Stratification by history of SPC:3000;
Countries of Recruitment:
China...